FDANonrulemakingFDA-2016-D-1270

Who commented on this docket

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases

14 organizations filed 15 public comments on Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases, at the Food and Drug Administration. The comment window closed 3582d ago.

Organizations
14
Comments
15
RIN
Comment window
closed 3582d ago

Commenters (14)

  • American Association for Cancer Researchtrade assoc.
    1 filing · confidence 85%
  • American Association for Clinical Chemistrytrade assoc.
    1 filing · confidence 85%
  • American Clinical Laboratory Associationtrade assoc.
    1 filing · confidence 85%
  • American Society of Hematologytrade assoc.
    1 filing · confidence 85%
  • American Society of Human Geneticstrade assoc.
    1 filing · confidence 85%
  • Association for Molecular Pathologytrade assoc.
    1 filing · confidence 85%
  • Genentech Incunverified attribution
    1 filing · confidence 70%
  • Leukemia & Lymphoma Societytrade assoc.
    1 filing · confidence 85%
  • Personalized Medicine Coalitiontrade assoc.
    1 filing · confidence 85%
  • Pfizer Inc.unverified attribution
    1 filing · confidence 70%
  • The Coalition for 21st Century Medicinetrade assoc.
    1 filing · confidence 85%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.